USZ0 Stock Overview
Engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
BPH Global Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.0005 |
| 52 Week High | AU$0.0025 |
| 52 Week Low | AU$0.0005 |
| Beta | 0.88 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -80.00% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -98.82% |
Recent News & Updates
Recent updates
Shareholder Returns
| USZ0 | DE Biotechs | DE Market | |
|---|---|---|---|
| 7D | 0% | -0.7% | -0.02% |
| 1Y | -80.0% | -17.2% | 8.2% |
Return vs Industry: USZ0 underperformed the German Biotechs industry which returned -17.2% over the past year.
Return vs Market: USZ0 underperformed the German Market which returned 8.2% over the past year.
Price Volatility
| USZ0 volatility | |
|---|---|
| USZ0 Average Weekly Movement | 0% |
| Biotechs Industry Average Movement | 6.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine USZ0's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | n/a | Matthew Leonard | www.scu.com.sg |
BPH Global Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia. The company’s products include raw bird’s nest and processed bird’s nest products, and Caulerpa Lentillifera, sea grapes and seaweeds. Its products are used in the food, nutrition, healthcare, health supplements, cosmetics and personal care industries.
BPH Global Ltd Fundamentals Summary
| USZ0 fundamental statistics | |
|---|---|
| Market cap | €742.58k |
| Earnings (TTM) | -€1.23m |
| Revenue (TTM) | €68.62k |
10.8x
P/S Ratio-0.6x
P/E RatioIs USZ0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| USZ0 income statement (TTM) | |
|---|---|
| Revenue | AU$109.97k |
| Cost of Revenue | AU$91.70k |
| Gross Profit | AU$18.27k |
| Other Expenses | AU$2.00m |
| Earnings | -AU$1.98m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.005 |
| Gross Margin | 16.61% |
| Net Profit Margin | -1,799.34% |
| Debt/Equity Ratio | -17.9% |
How did USZ0 perform over the long term?
See historical performance and comparison